Why cancer spreads more in middle age than in old age? Study may surprise you

Cancer becomes more common with age and is often harder to treat in older adults, yet most cancer studies do not reflect that reality.

A study reveals a new form of cancer, melanoma, may be most dangerous in middle age, as cancer briefly gains the upper hand against the immune system before losing it again in extreme old age.

In a surprising discovery, researchers found that cancer spread was lowest in young mice, surged in middle-aged mice, and then dropped again in very old mice.

While melanoma may not become steadily more dangerous with age as scientists once assumed. It happens as researchers believe a specialized group of immune cells known as gamma delta (γδ) T cells may help explain the surprising pattern.

These cells act as an early defense system, helping prevent cancer from spreading throughout the body. Young mice and very old mice had higher levels of these protective immune cells, and their tumors were more likely to remain dormant or spread less aggressively.

Middle-aged mice told a different story, as they had fewer Y & T cells, and melanoma was much more likely to spread to organs such as the lungs and liver.

Fewer than 10% of mouse experiments use aged animals, with researchers typically relying on mice that roughly correspond to humans in their early 20s.

That gap may help explain why many cancer therapies that perform well in laboratory studies ultimately fail in human clinical trials.

The new findings suggest that changes in the immune system over the course of aging may play an important role in determining when cancer is most likely to spread. 

They also highlight the importance of including older animals in cancer research to better reflect the patients most affected by the disease.

Additionally, the research materials were provided by Temple University Health System and the findings by Fox Chase Cancer Center, presented at the American Association for Cancer Research annual meeting were published in the Cancer Research, 2026 journal with titled as "Role of Aging on the ᵧδ T-cells in Metastatic Cutaneous Melanoma Progression."